"JC Virus/drug effects"[MeSH] - Search Results

Year	Number of Results
1993	1
1995	2
1996	2
1998	1
1999	1
2000	1
2001	1
2002	1
2003	2
2005	2
2006	4
2007	5
2008	9
2009	10
2010	8
2011	3
2012	8
2013	6
2014	9
2015	2
2016	13
2017	2
2018	3
2019	6
2020	6
2021	3
2024	0

1

JC Polyomavirus Infection Potentiated by Biologics.

Multani A, Ho DY. Multani A, et al. Infect Dis Clin North Am. 2020 Jun;34(2):359-388. doi: 10.1016/j.idc.2020.02.007. Infect Dis Clin North Am. 2020. PMID: 32444013 Review.

2

Progressive multifocal leukoencephalopathy: new concepts.

Lima MA. Lima MA. Arq Neuropsiquiatr. 2013 Sep;71(9B):699-702. doi: 10.1590/0004-282X20130154. Arq Neuropsiquiatr. 2013. PMID: 24141508 Free article. Review.

3

Update on progressive multifocal leukoencephalopathy.

Steiner I, Berger JR. Steiner I, et al. Curr Neurol Neurosci Rep. 2012 Dec;12(6):680-6. doi: 10.1007/s11910-012-0313-4. Curr Neurol Neurosci Rep. 2012. PMID: 22991070 Review.

4

Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.

Beck ES, Cortese I. Beck ES, et al. Curr Opin Virol. 2020 Feb;40:19-27. doi: 10.1016/j.coviro.2020.02.005. Epub 2020 Apr 9. Curr Opin Virol. 2020. PMID: 32279025 Review.

5

Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.

Marshall LJ, Major EO. Marshall LJ, et al. J Neuroimmune Pharmacol. 2010 Sep;5(3):404-17. doi: 10.1007/s11481-010-9203-1. Epub 2010 Apr 17. J Neuroimmune Pharmacol. 2010. PMID: 20401541 Free PMC article. Review.

6

Steroids for PML-IRIS: a double-edged sword?

Berger JR. Berger JR. Neurology. 2009 Apr 28;72(17):1454-5. doi: 10.1212/01.wnl.0000343735.44983.5e. Epub 2009 Jan 14. Neurology. 2009. PMID: 19144930 No abstract available.

7

Mycophenolate: encephalopathy.

[No authors listed] [No authors listed] Prescrire Int. 2008 Dec;17(98):245. Prescrire Int. 2008. PMID: 19431230 No abstract available.

8

Prospective monitoring of cytomegalovirus, Epstein-Barr virus, BK virus, and JC virus infections on belatacept therapy after a kidney transplant.

Bassil N, Rostaing L, Mengelle C, Kallab S, Esposito L, Guitard J, Cardeau-Desangles I, Weclawiak H, Izopet J, Kamar N. Bassil N, et al. Exp Clin Transplant. 2014 Jun;12(3):212-9. Exp Clin Transplant. 2014. PMID: 24907721 Free article. Clinical Trial.

9

Reassessing the risk of natalizumab-associated PML.

Berger JR, Fox RJ. Berger JR, et al. J Neurovirol. 2016 Aug;22(4):533-5. doi: 10.1007/s13365-016-0427-6. Epub 2016 Feb 3. J Neurovirol. 2016. PMID: 26843383

10

The risk of progressive multifocal leukoencephalopathy under biological agents used in the treatment of chronic inflammatory diseases.

Toussirot É, Bereau M. Toussirot É, et al. Inflamm Allergy Drug Targets. 2014;13(2):121-7. doi: 10.2174/1871528113666140224103712. Inflamm Allergy Drug Targets. 2014. PMID: 24559124 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

99 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year